Qlaris Bio, Inc.
Qlaris Bio, Inc.
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Single-site Pilot Study Evaluating the Effect of QLS-111 Ophthalmic Solution on Posterior Perfusion and Vessel Dilation | Diabetes Complications, cardiovascular disorder, diabetes mellitus, diabetic peripheral angiopathy, diabetic retinopathy, endocrine system disorder, eye disorder, glaucoma, low tension glaucoma, ocular hypertension, open-angle glaucoma, optic nerve disorder, retinal disorder, vascular disorder | Active, not recruiting | Phase 2 | 2026-09-14 | NCT07354477 |